Date: 2018-07-09
Type of information: Nomination
Compound: member of the board of directors
Company: Orchard Therapeutics (UK)
Therapeutic area: Rare diseases - Genetic diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On July 9, 2018, Orchard Therapeutics announced the appointment of Joanne Beck to its board of directors. Dr. Beck is currently the executive vice president of pharmaceutical development and operations and a member of the executive committee at Celgene. Prior to Celgene, Dr. Beck was senior vice president of pharmaceutical development at Shire from 2012 to 2016. Before Shire, she held various leadership positions in Abbott’s global pharmaceutical operations and was the site head of Abbott Vascular Instruments GmbH. Earlier in her career, Dr. Beck held positions in process development at Genentech and Amgen. She holds a Bachelor of Arts degree from Lewis and Clark College and a Ph.D. from the University of Oregon Medical School.
Financial terms:
Latest news:
Is general: Yes
